The British pharmaceutical sector accounted for around 2.7%
of production value in the manufacturing sector in the UK in
2015. In the last two decades, levels have never exceeded 4%.
The importance of the British pharmaceutical industry is greater than
might be assumed fromthis percentage share, since mature indus-
trialised countries are increasingly declining in importance as pro-
duction sites for pharmaceuticals, so far as basic products are con-
The head offices and European headquarters of prominent
global pharma producers and many biotech companies are based
in the UK which is the largest recipient of EU research funding
(16%) . The European Medicines Agency (EMA) – which is tasked
with monitoring, assessing and approving human and veterinary
drugs in Europe – is also based in London.